Evaluation of the effectiveness of the “TRIO” pharmacotherapy regimen in patients with chronic arterial insufficiency IIb-III

Authors

  • Viktoriia Petrushenko National Pirogov Memorial Medical University, Vinnytsia
  • Dmytro Hrebeniuk National Pirogov Memorial Medical University, Vinnytsia
  • Oleh Skupyi National Pirogov Memorial Medical University, Vinnytsia
  • Kostiantyn Lonskyi National Pirogov Memorial Medical University, Vinnytsia
  • Vadym Stoika Vinnytsia Regional Clinical Hospital n.a. M. I. Pirogov

DOI:

https://doi.org/10.31636/prmd.v3i1.1

Keywords:

occlusion disease of the peripheral arteries, chronic arterial insufficiency, Latren, Rheosorbilact, Tivortin, painless walking distance, peripheral oxygen saturation, intensity of pain, ankle-brachial pressure index

Abstract

Background. Despite constant progress in the study of the etiopathogenetic aspects of the disease, the development and implementation of new methods of treatment, the search for optimal pharmacotherapy regimens, the problem of occlusion disease of the peripheral arteries of the lower extremities continues to be extremely relevant.

The aim of the study was to evaluate the effectiveness of the “TRIO” pharmacotherapy regimen in patients with chronic arterial insufficiency IIb-III.

Materials and methods. According to the aims and objectives, 45 patients with a confirmed diagnosis of peripheral arterial occlusive disease of the lower extremities and chronic arterial insufficiency IIb-III were included in the study. All patients from the study population were randomly divided into two groups. Patients from experimental group received “TRIO” pharmacotherapy (Latren, Rheosorbilact, Tivortin). Patients from comparison group received medical therapy with Rheosorbilact and Tivortin.

Results. The duration of hospital stay was significantly shorter (p < 0.01) in the experimental group (7.9 ± 0.97 days) than in the comparison group (9.8 ± 1.63 days). After treatment painless walking distance and peripheral oxygen saturation were significantly greater (p < 0.01) in the experimental group (126.25 ± 72.16 m and 90.65 ± 5.07 %, respectively) than in the comparison group (54.20 ± 33.59 m and 79.48 ± 6.91 %, respectively). At the same time, the intensity of pain was significantly lower (p < 0.01) in the experimental group (3.25 ± 1.68 points) than in the comparison group (4.80 ± 1.53 points). The values of the ankle-brachial pressure index were not differing (p < 0.05) in both groups (0.49 ± 0.16 and 0.51 ± 0.17 for the experimental group and comparison group, respectively).

Conclusions. “TRIO” pharmacotherapy regimen in patients with chronic arterial insufficiency IIb–III allows to improve the basic indicators of the functional state of the microvasculature of the lower extremities.

Downloads

Download data is not yet available.

References

Savji N, Rockman CB, Skolnick AH. Association Between Advanced Age and Vascular Disease in Different Arterial Territories: A Population Database of Over 3.6 Million Subjects. Journal of Vascular Surgery [Internet]. Elsevier BV; 2013 Dec;58(6):1719–20. Available from: https://doi.org/10.1016/j.jvs.2013.10.044

Anand RG, Ventura HO, Mehra MR. Is Heart Failure More Prevalent in Patients With Peripheral Arterial Disease? A Meta-Analysis. Congestive Heart Failure [Internet]. Wiley; 2007 Nov;13(6):319–22. Available from: https://doi.org/10.1111/j.1527-5299.2007.07344.x

Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. Journal of the American College of Cardiology. 2006 Mar 7;47(5):921-9. https://doi.org/10.1016/j.jacc.2005.09.065.

Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabetic Medicine [Internet]. Wiley; 2009 Feb;26(2):142–8. Available from: https://doi.org/10.1111/j.1464-5491.2008.02640.x

Hiatt WR, Fowkes FGR, Heizer G, Berger JS, Baumgartner I, Held P, et al. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease. New England Journal of Medicine [Internet]. Massachusetts Medical Society; 2017 Jan 5;376(1):32–40. Available from: https://doi.org/10.1056/nejmoa1611688

Høyer C, Sandermann J, Petersen LJ. The toe-brachial index in the diagnosis of peripheral arterial disease. Journal of Vascular Surgery [Internet]. Elsevier BV; 2013 Jul;58(1):231–8. Available from: https://doi.org/10.1016/j.jvs.2013.03.044

Thukkani AK, Kinlay S. Endovascular Intervention for Peripheral Artery Disease. Circulation Research [Internet]. Ovid Technologies (Wolters Kluwer Health); 2015 Apr 24;116(9):1599–613. Available from: https://doi.org/10.1161/circresaha.116.303503

Wrobel JS, Mayfield JA, Reiber GE. Geographic Variation of Lower-Extremity Major Amputation in Individuals With and Without Diabetes in the Medicare Population. Diabetes Care [Internet]. American Diabetes Association; 2001 May 1;24(5):860–4. Available from: https://doi.org/10.2337/diacare.24.5.860

Steffen LM, Duprez DA, Boucher JL, Ershow AG, Hirsch AT. Management of Peripheral Arterial Disease. Diabetes Spectrum [Internet]. American Diabetes Association; 2008 Jul;21(3):171–7. Available from: https://doi.org/10.2337/diaspect.21.3.171

Firnhaber JM, Powell CS. Lower Extremity Peripheral Artery Disease: Diagnosis and Treatment. Am Fam Physician. 2019 Mar 15;99(6):362-369. https://www.ncbi.nlm.nih.gov/pubmed/30874413

Оцінка ефективності схеми фармакотерапії “ТРІО” у пацієнтів із хронічною артеріальною недостатністю ІІb–ІІІ

Published

2020-06-01

How to Cite

1.
Petrushenko V, Hrebeniuk D, Skupyi O, Lonskyi K, Stoika V. Evaluation of the effectiveness of the “TRIO” pharmacotherapy regimen in patients with chronic arterial insufficiency IIb-III. prmd [Internet]. 2020Jun.1 [cited 2020Nov.25];3(1):4-9. Available from: https://perioperative.org.ua/index.php/prtmdc/article/view/37